Results 271 to 280 of about 212,106 (307)

Detection of Minimal Residual Disease

1995
The ability to detect neoplastic infiltration is important not only for the accurate staging of disease at diagnosis but also to monitor the response to therapy. Although adult patients with advanced malignancies often achieve clinical complete remission, the majority of these patients ultimately relapse.
J, Gribben, L, Nadler
openaire   +2 more sources

Minimal residual disease in gastrointestinal cancer

Seminars in Surgical Oncology, 2001
AbstractTumor progression after curative resection of gastrointestinal carcinomas is probably caused by pre‐ or intraoperative tumor cell dissemination. Disseminated tumor cells are generally detected by immunohistochemistry‐ or PCR‐based molecular‐biology methods. A consensus on which is the most adequate detection method has not yet been found, which
P, Kienle, M, Koch
openaire   +2 more sources

Markers of Minimal Residual Disease

1982
Current methods employing tumour markers to detect small amounts of residual disease are reviewed with respect to human germ cell, colorectal and breast neoplasms. It is concluded that the assay of tumour markers in body fluids has only limited clinical value. Alternative approaches, such as are afforded by radioimmunodetection and immunocytochemistry,
openaire   +2 more sources

Kinetics of Minimal Residual Disease

1979
The development of a rational approach to adjuvant chemotherapy of cancer depends upon at least four factors: 1. Recognition that micrometastases are frequently disseminated and established prior to the time of surgery for a primary cancer; 2.
openaire   +2 more sources

Minimal Residual Disease

2019
Jacques J. M. van Dongen, Tomasz Szczepański, Vincent H. J. van der Velden   +2 more
openaire   +1 more source

Photodynamic therapy of cancer: An update

Ca-A Cancer Journal for Clinicians, 2011
Patrizia M Agostinis, Kristian Berg, Keith A Cengel   +2 more
exaly  

Expectant management for men with early stage prostate cancer

Ca-A Cancer Journal for Clinicians, 2015
Mark S Litwin
exaly  

Minimal Residual Disease ☆

2013
openaire   +1 more source

Liquid biopsy and minimal residual disease — latest advances and implications for cure

Nature Reviews Clinical Oncology, 2019
Klaus Pantel, Catherine Alix-Panabières
exaly  

Minimal residual disease

2006
Dario Campana, Andrea Biondi, Jacques J. M. van Dongen   +2 more
openaire   +1 more source